26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
If January's minimum wage, tip, and overtime developments forecast what employers should expect thro...
Read More >
We previously reported on the San Antonio sick leave ordinance that was to become effective August 1...
Read More >
Depending on a tech start-up company’s initial financial condition, many tech start-ups are sometim...
Read More >
Immigration, Refugees and Citizenship Canada (IRCC), and Employment and Social Development Canada (E...
Read More >
In a decision unsurprising to anyone familiar with what California juries have been up to lately, fa...
Read More >
Focus On Whistleblower Protections - Avoiding and Defending Whistleblower Claims - Defending Sarba...
Read More >